ISRG Stock Recent News

Over the past several years, one of the most impressive stocks in the healthcare sector has undeniably been Intuitive Surgical NASDAQ: ISRG. The company's robotics-assisted surgical devices have proven to be extremely innovative, attracting intense demand from doctors around the globe.

Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $512.11, marking a -1.34% move from the previous day.

ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $522.41, marking a -1.36% move from the previous day.

Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case.

Intuitive Surgical ISRG is currently in Phase 17 of its 18-Phase Adhishthana Cycle. While the recent correction may be causing concern among investors, from the perspective of Adhishthana Principles, the pullback appears not only expected but also healthy.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The S&P 500 index tracks the stock performance of America's biggest companies, and it has averaged annual gains of roughly 10% over multiple decades. That's pretty darn good performance, enough to more than quintuple an investment over 15 years for those who purchased exchange-traded funds (ETFs) mirroring the index.